Long-term follow-up for MB-105 recipients
This study is a long-term follow-up for people who already received an experimental treatment called MB-105 in a previous study. It helps researchers see how you're doing over time and collect extra information about the treatment's lasting effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You received the experimental treatment MB-105 in an earlier study.
- You are willing to sign a consent form to join this follow-up.
- You agree to let us transfer your medical samples from the earlier study to this one.
- You can follow the study's rules, such as coming for check-ups when asked.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with Parkinson's disease or multiple system atrophy (parkinsonian type) who took part in an earlier AB-1005 study. It will continue to monitor your health over time to learn more about the treatment's long-term effects.
This study is a long-term follow-up for people who have already received the investigational drug CLBR001. It aims to monitor their health over time after the treatment.
This study checks how well a previous early breast cancer treatment works over the long term and monitors safety. It may help you and future patients by providing long-term results from the original trial.
This long-term follow-up study looks at people who received mentalization-based treatment (a type of therapy) more than 10 years ago for a personality disorder. The goal is to learn how their lives have changed and what value the treatment may have had over time.
This study checks how people are doing long-term after they previously received a treatment called HMI 102. It may help researchers understand long-term safety and outcomes so future patients can be better supported.
This study follows people with Huntington's disease who had a brain cell transplant in the MIG-HD trial. It checks how they are doing over time to learn more about the long-term effects of the transplant.
Hear when a new Any Patient Treated With MB-105 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.